Mylan Laboratories Limited

Form 483 issued September 14, 2016 · Sinnar, India

Inspection
Sep 5 – Sep 14, 2016
Investigator
Massoud Motamed
Observations
1
Pages
10
FEI number
3005587313

In short: On September 14, 2016, FDA issued a Form 483 with 1 observation to Mylan Laboratories Limited in Sinnar, India (FEI 3005587313) after an inspection that ran Sep 5 – Sep 14, 2016. The investigator was Massoud Motamed. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

1 of 1 observations on this 483 concern laboratory controls.

Laboratory controls1

Most cited: 21 CFR 211.165(e) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The accuracy, sensitivity, specificity and reproducibility of test methods have not been established and documented. (a)…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mylan Laboratories Limited?

FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Mylan Laboratories Limited?

Massoud Motamed is named on this Form 483, for the inspection of Sep 5 – Sep 14, 2016. Each investigator has a profile showing what they cite most.

When was Mylan Laboratories Limited inspected by FDA?

The inspection ran Sep 5 – Sep 14, 2016, and the Form 483 is dated September 14, 2016.

How do I get the full Form 483 for Mylan Laboratories Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free